Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

[Treatment with rituximab of autoimmune disease: results from AADEA's registry].

Callejas Rubio JL, Camps MT, García-Hernández F; Asociación Andaluza de Enfermedades Autoinmunes..

Med Clin (Barc). 2008 Jan 26;130(2):79. Spanish. No abstract available.

PMID:
18221681
2.

[Rituximab for treatment of patients with systemic autoimmune diseases].

García Hernández FJ, Ocaña Medina C, González León R, Garrido Rasco R, Colorado Bonilla R, Castillo Palma MJ, Sánchez Román J.

Med Clin (Barc). 2007 Mar 31;128(12):458-62. Spanish.

PMID:
17408540
3.

Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).

Scheinberg M, Hamerschlak N, Kutner JM, Ribeiro AA, Ferreira E, Goldenberg J, Kiss MH, Chahade WH.

Clin Exp Rheumatol. 2006 Jan-Feb;24(1):65-9.

PMID:
16539821
4.

Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.

Avshovich N, Boulman N, Slobodin G, Zeina AR, Rosner I, Rozenbaum M.

Isr Med Assoc J. 2009 Sep;11(9):566-8. No abstract available.

5.

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Ramos-Casals M, García-Hernández FJ, de Ramón E, Callejas JL, Martínez-Berriotxoa A, Pallarés L, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Pérez-Alvarez R, Micó ML, Medrano F, Gómez de la Torre R, Díaz-Lagares C, Camps M, Ortego N, Sánchez-Román J; BIOGEAS Study Group..

Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30.

PMID:
20525449
6.

[Good response to treatment with rituximab in a child with refractory idiopathic thrombocytopenic purpura].

Fríguls-Francitorra B, Almazán-Castro F, Manchón GJ.

Med Clin (Barc). 2006 Sep 30;127(12):478-9. Spanish. No abstract available.

PMID:
17040639
7.

Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus.

Limal N, Cacoub P, Sène D, Guichard I, Piette JC.

Lupus. 2008 Jan;17(1):69-71. No abstract available.

PMID:
18089688
8.

Rituximab for severe refractory pediatric Wegener granulomatosis.

Patel AM, Lehman TJ.

J Clin Rheumatol. 2008 Oct;14(5):278-80. doi: 10.1097/RHU.0b013e3181886064.

PMID:
18824926
9.

B cell depletion in autoimmune disease.

Gorman C, Leandro M, Isenberg D.

Arthritis Res Ther. 2003;5 Suppl 4:S17-21. Epub 2003 Oct 2. Review.

10.

Rituximab off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks.

Sailler L.

Clin Rev Allergy Immunol. 2008 Feb;34(1):103-10. doi: 10.1007/s12016-007-8020-7. Review.

PMID:
18270863
11.

Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.

Tektonidou MG, Skopouli FN.

Clin Exp Rheumatol. 2006 Mar-Apr;24(2 Suppl 41):S103. No abstract available.

PMID:
16859607
12.

Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus.

Hundae A, Peskoe S, Grimsley E, Patel S.

South Med J. 2008 Sep;101(9):943-4. doi: 10.1097/SMJ.0b013e3181809ebd.

PMID:
18708978
13.

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.

Silverman GJ, Weisman S.

Arthritis Rheum. 2003 Jun;48(6):1484-92. Review. No abstract available.

14.

Slow responses to standard dose rituximab in immune thrombocytopenic purpura.

Kelly K, Gleeson M, Murphy PT.

Haematologica. 2009 Mar;94(3):443-4; author reply 444-5. doi: 10.3324/haematol.2008.001396. No abstract available.

15.

Clinical, biological and ultrasonographic remission in a patient with musculoskeletal systemic lupus erythematosus with rituximab.

Torrente-Segarra V, Lisbona-Pérez M, Rotes-Sala D, Castro-Oreiro S, Carbonell-Abelló J.

Lupus. 2009 Mar;18(3):270-2. doi: 10.1177/0961203308095001.

PMID:
19213868
16.

New therapies for systemic lupus erythematosus: cellular targets.

Looney RJ, Anolik J, Sanz I.

Rheum Dis Clin North Am. 2006 Feb;32(1):201-15, xi. Review.

PMID:
16504831
17.
18.

[Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].

Lehembre S, Macario-Barrel A, Musette P, Carvalho P, Joly P.

Ann Dermatol Venereol. 2006 Jan;133(1):53-5. French.

PMID:
16495854
19.

Rituximab use in pediatric autoimmune diseases: four case reports.

Polido-Pereira J, Ferreira D, Rodrigues AM, Nascimento C, Costa P, Almeida M, da Silva JE, Simão C, Stone R, Ramos F, Neto A, da Costa JC, Melo-Gomes J, Gomes-Pedro J, Viana-Queiroz M, Canhão H, Fonseca JE.

Ann N Y Acad Sci. 2009 Sep;1173:712-20. doi: 10.1111/j.1749-6632.2009.04804.x.

PMID:
19758220
20.

Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus.

Lee JW, Kim HA, Sung JM, Suh CH.

Lupus. 2010 Feb;19(2):227-8. doi: 10.1177/0961203309345723. Epub 2009 Nov 2. No abstract available.

PMID:
19884220

Supplemental Content

Support Center